Neurogene Inc.

NASDAQ: NGNE · Real-Time Price · USD
14.73
-0.27 (-1.80%)
At close: May 09, 2025, 3:59 PM
14.73
0.00%
After-hours: May 09, 2025, 04:05 PM EDT

Neurogene Revenue Breakdown

Period Ending Dec 31, 2024
Reportable Segment Revenue 925K
Reportable Segment Revenue Growth n/a

Operating Expense Breakdown

Period Ending Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017 Dec 31, 2016 Sep 30, 2016
Selling, General, and Administrative Revenue 6.17M 5.89M 5.32M 4.41M 2.55K 4.57M 2.27M 3.41M 3.61M 2.18M 4.2M 4M 4.78M 4.96M 4.76M 4.73M 4.39M 3.42M 4.18M 3.4M 3.37M 10.18M 2.22M 2.35M 2.83M 3.88M 4.51M 4.51M 4.97M 3.61M 3.52M 2.75M 3.33M 2.15M
Selling, General, and Administrative Revenue Growth +4.58% +10.91% +20.44% +173026.72% -99.94% +100.92% -33.32% -5.41% +65.76% -48.15% +4.85% -16.31% -3.65% +4.33% +0.61% +7.67% +28.46% -18.13% +22.75% +1.01% -66.92% +357.94% -5.61% -16.73% -27.19% -13.96% +0.11% -9.33% +37.60% +2.67% +28.23% -17.59% +55.00% n/a
Research and Development Revenue 15.35M 16.29M 15.74M 13.54M 34.62M 617K 10.32M 7.69M 10M 10.82M 10.96M 10.7M 9.76M 9.9M 9.82M 9.71M 7.79M 6.22M 4.84M 5.5M 4.89M 1.42M 5K 4K 1.47M 2.81M 18M 10.51M 11.56M 8.46M 10.47M 5.78M 8.13M 6.13M
Research and Development Revenue Growth -5.76% +3.44% +16.27% -60.89% +5510.86% -94.02% +34.21% -23.11% -7.60% -1.20% +2.38% +9.64% -1.37% +0.73% +1.21% +24.66% +25.27% +28.35% -11.91% +12.48% +244.23% +28300.00% +25.00% -99.73% -47.67% -84.37% +71.26% -9.09% +36.70% -19.27% +81.32% -28.96% +32.57% n/a